Taber is an associate in the Life Sciences Health Industry Group, practicing primarily in the areas of regulatory compliance and due diligence. His practice includes counselling medical device companies on FDA regulatory compliance and staying abreast of FDA guidance in developing areas. He has helped medical device companies defend against unfair and deceptive advertising and assisted with advertising compliance efforts. He is also actively helping a number of clients defend against government investigations, including multiple FTC investigations related to data sharing and transmission and state AG investigations related to health care infection control.